Abstract

Summary

This review highlights how non-invasive ocular assessments — including saccade patterns, pupillary responses, blinking, and retinal microvasculature imaging — can serve as early diagnostic biomarkers for cognitive and psychiatric disorders. For lighting and healthcare environments, these findings suggest that monitoring ocular responses could support early screening and intervention programs, particularly relevant in settings where circadian light exposure affects pupillary and retinal health.
Abstract

Key Findings

  • Saccades, pupillary responses, and blinking patterns are identified as potential biomarkers for Alzheimer's disease, ASD, schizophrenia, and major depressive disorder.
  • Retinal microvasculature and morphology visualized through office-based ophthalmic imaging show promise for non-invasive cognitive disorder screening.
  • Machine-learning and deep-learning AI approaches are emerging as tools to interpret ocular biomarker data for cognitive and psychiatric disorder evaluation.
  • Review concludes that ocular assessments offer a non-invasive, real-time window into central nervous system function tied to emotional and cognitive processing.
Categories

Categories

Eye Health & Vision: Reviews ocular biomarkers (saccades, pupillary responses, retinal microvasculature) as diagnostic tools for cognitive and psychiatric disorders.
Dementia & Elder Care: Discusses ocular assessment approaches for early diagnosis of Alzheimer's disease using retinal imaging and eye movement patterns.
Mood & Mental Wellness: Covers ocular biomarkers relevant to major depressive disorder, autism spectrum disorder, and schizophrenia screening.
Authors

Author(s)

X Li, X Chen, F Fan, L Ning, K Lin, Z Chen
Publication Date

Publication Year

2019
View more publications